Michelle Melisko
0000-0002-8729-4667
Publication & Citation Trends
Publications
0 total
Abstract PS1-02-29: Sexual health communication preferences of women with metastatic breast cancer
Cited by 0
Semantic Scholar
Abstract RF1-04: Early Adverse Symptoms Predict Response to Treatment Among Patients in the I-SPY Trial
Cited by 0
Semantic Scholar
Abstract PS5-08-11: Trial in Progress: Phase II Open-Label Study of ARX788 (anti-HER2 Antibody Drug Conjugate (ADC)) for Patients with HER2-Low Locally Advanced Unresectable or Metastatic Breast Cancer
Cited by 0
Semantic Scholar
Tucatinib–trastuzumab–capecitabine for treatment of leptomeningeal metastasis in women with HER2+ breast cancer: TBCRC049 phase 2 study results
Cited by 0
Semantic Scholar
Abstract PS1-03-19: Interventions acceptable to women with metastatic breast cancer for their sexual problems
Cited by 0
Semantic Scholar
Abstract PS1-01-15: A real-world experience of treatment rechallenge after grade 1 trastuzumab-deruxtecan related interstitial lung disease: clinical outcomes and blinded imaging review
Cited by 0
Semantic Scholar
Abstract PS1-01-01: Evaluating the use, self-reported outcomes, and cost of using scalp cooling in a prospective survey study of young women with early-stage breast cancer
Cited by 0
Semantic Scholar
Detection of actionable mutations in the cerebrospinal fluid and concordance/discordance with extracranial mutations in patients with metastatic breast cancer and leptomeningeal disease
Cited by 0
Semantic Scholar
Research Topics
Cancer Treatment and Pharmacology
(84)
Breast Cancer Treatment Studies
(69)
Cancer survivorship and care
(66)
HER2/EGFR in Cancer Research
(60)
Brain Metastases and Treatment
(57)
Affiliations
University of North Carolina at Chapel Hill
University of Minnesota
Research Triangle Park Foundation
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa
Mayo Clinic